Common problems related to the use of number needed to treat
- PMID: 19880287
- DOI: 10.1016/j.jclinepi.2009.08.006
Common problems related to the use of number needed to treat
Abstract
Objective: To illustrate basic issues that have to be taken into account when study results are presented by means of the number needed to treat (NNT).
Study design and setting: This article presents an overview of common problems related to the NNT with corresponding explanations.
Results: Without stating the direction of the effect, the alternative treatment, the treatment period, and the follow-up period, information in terms of NNTs is uninterpretable. The naive use of person-time data for the calculation of NNTs is frequently inappropriate. Rounding NNTs to the next upward integer may obscure differences among therapies.
Conclusions: The basic information about which treatments are compared, the treatment period, the follow-up period, and the direction of the effect should be given when study results are presented in terms of NNTs. Adequate methods should be used for point and interval estimation of NNTs. Unnecessary rounding of NNTs should be avoided. In more complicated situations of confounding or varying follow-up times, the use of more sophisticated methods is required with increasing potential for misinterpretation.
Copyright (c) 2010 Elsevier Inc. All rights reserved.
Similar articles
-
Number needed to treat is incorrect without proper time-related considerations.J Clin Epidemiol. 2012 Jan;65(1):42-6. doi: 10.1016/j.jclinepi.2011.04.009. Epub 2011 Aug 4. J Clin Epidemiol. 2012. PMID: 21816576
-
Number needed to treat estimates incorporating effects over the entire range of clinical outcomes: novel derivation method and application to thrombolytic therapy for acute stroke.Arch Neurol. 2004 Jul;61(7):1066-70. doi: 10.1001/archneur.61.7.1066. Arch Neurol. 2004. PMID: 15262737
-
Estimating adjusted NNTs in randomised controlled trials with binary outcomes: a simulation study.Contemp Clin Trials. 2010 Sep;31(5):498-505. doi: 10.1016/j.cct.2010.07.005. Epub 2010 Jul 17. Contemp Clin Trials. 2010. PMID: 20624484
-
Annualized was found better than absolute risk reduction in the calculation of number needed to treat in chronic conditions.J Clin Epidemiol. 2006 Mar;59(3):217-23. doi: 10.1016/j.jclinepi.2005.07.006. Epub 2005 Oct 13. J Clin Epidemiol. 2006. PMID: 16488351 Review.
-
Assessing the validity of clinical trials.J Pediatr Gastroenterol Nutr. 2008 Sep;47(3):277-82. doi: 10.1097/MPG.0b013e31816c749f. J Pediatr Gastroenterol Nutr. 2008. PMID: 18728521 Review.
Cited by
-
Statins After Myocardial Infarction in the Oldest: A Cohort Study in the Clinical Practice Research Datalink Database.J Am Geriatr Soc. 2020 Feb;68(2):329-336. doi: 10.1111/jgs.16227. Epub 2019 Oct 24. J Am Geriatr Soc. 2020. PMID: 31647578 Free PMC article.
-
Comparative effectiveness of postoperative chemotherapy among older patients with non-metastatic rectal cancer treated with preoperative chemoradiotherapy.J Geriatr Oncol. 2016 May;7(3):176-86. doi: 10.1016/j.jgo.2016.01.011. Epub 2016 Feb 23. J Geriatr Oncol. 2016. PMID: 26926829 Free PMC article.
-
Utility of the number needed to treat in paediatric haematological cancer randomised controlled treatment trials: a systematic review.BMJ Open. 2019 Feb 20;9(2):e022839. doi: 10.1136/bmjopen-2018-022839. BMJ Open. 2019. PMID: 30787076 Free PMC article.
-
CHEMOPROPHYLAXIS TO CONTROL LEPROSY AND THE PERSPECTIVE OF ITS IMPLEMENTATION IN BRAZIL: A PRIMER FOR NON-EPIDEMIOLOGISTS.Rev Inst Med Trop Sao Paulo. 2015 Dec;57(6):481-7. doi: 10.1590/S0036-46652015000600004. Rev Inst Med Trop Sao Paulo. 2015. PMID: 27049701 Free PMC article.
-
Balancing Benefits and Harms of COVID-19 Vaccines: Lessons from the Ongoing Mass Vaccination Campaign in Lombardy, Italy.Vaccines (Basel). 2022 Apr 15;10(4):623. doi: 10.3390/vaccines10040623. Vaccines (Basel). 2022. PMID: 35455374 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources